1. Home
  2. GKOS vs PCQ Comparison

GKOS vs PCQ Comparison

Compare GKOS & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • PCQ
  • Stock Information
  • Founded
  • GKOS 1998
  • PCQ 2001
  • Country
  • GKOS United States
  • PCQ United States
  • Employees
  • GKOS N/A
  • PCQ N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • PCQ Investment Managers
  • Sector
  • GKOS Health Care
  • PCQ Finance
  • Exchange
  • GKOS Nasdaq
  • PCQ Nasdaq
  • Market Cap
  • GKOS 5.4B
  • PCQ 163.2M
  • IPO Year
  • GKOS 2015
  • PCQ N/A
  • Fundamental
  • Price
  • GKOS $84.22
  • PCQ $8.77
  • Analyst Decision
  • GKOS Strong Buy
  • PCQ
  • Analyst Count
  • GKOS 12
  • PCQ 0
  • Target Price
  • GKOS $128.58
  • PCQ N/A
  • AVG Volume (30 Days)
  • GKOS 698.9K
  • PCQ 69.6K
  • Earning Date
  • GKOS 11-03-2025
  • PCQ 01-01-0001
  • Dividend Yield
  • GKOS N/A
  • PCQ 4.63%
  • EPS Growth
  • GKOS N/A
  • PCQ N/A
  • EPS
  • GKOS N/A
  • PCQ N/A
  • Revenue
  • GKOS $432,953,000.00
  • PCQ N/A
  • Revenue This Year
  • GKOS $28.79
  • PCQ N/A
  • Revenue Next Year
  • GKOS $25.65
  • PCQ N/A
  • P/E Ratio
  • GKOS N/A
  • PCQ N/A
  • Revenue Growth
  • GKOS 26.70
  • PCQ N/A
  • 52 Week Low
  • GKOS $77.10
  • PCQ $8.19
  • 52 Week High
  • GKOS $163.71
  • PCQ $10.50
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 40.34
  • PCQ 83.85
  • Support Level
  • GKOS $80.53
  • PCQ $8.60
  • Resistance Level
  • GKOS $95.32
  • PCQ $8.82
  • Average True Range (ATR)
  • GKOS 2.90
  • PCQ 0.07
  • MACD
  • GKOS -0.95
  • PCQ 0.05
  • Stochastic Oscillator
  • GKOS 22.82
  • PCQ 91.53

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.

Share on Social Networks: